2 Firms Score $5.6M For Work On $18.7M Chiasma Deal
By Aaron Leibowitz ( June 28, 2019, 1:13 PM EDT) -- A Boston federal court has awarded Robbins Geller Rudman & Dowd LLP and Johnson Fistel LLP over $5.6 million in attorney fees for their work securing an $18.7 million settlement in an investor class action alleging biopharmaceutical company Chiasma misrepresented a drug's chances for winning FDA approval....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.